The Science of Digestive Health (Digesting the Facts: Probiotics, Prebiotics and Enzymes for Improved Digestion)

Somlynn Rorie

06/13/2008

References:


 


   1. Grounlund, MM et al. “Fecal micorflora in healthy infants born by different methods of delivery:permanent changes in intestinal flora after cesarean delivery” J Perdatr Gastroenterol Nutr. 1999;28(1): 19-25.


 


   2. Rubaltelli, FF et al. “Intestinal flora in breast- and bottle-fed infants.” J Perinat Med. 1998;26(3):186-191.


 


   3.  Indrio, F et al. “The effects of probiotics on feeding tolerance, bowel habits and gastrointestinal motility in preterm newborns” J Pediatr. 2008;152(6):801-6.


 


   4. Trois, L et al. “Use of probiotics in HIV-infected children: a randomized double-blind controlled study” J Trop Pediatr. 2008;54(1):19-24.


 


   5. Svante, T et al. “Probiotics and oral health effects in children”  Int J Paediatr Dent. 2008;18(1):3-10.


 


   6. Burks, E. “Probiotics in the prevention of atopic disease in children” Agro Food Industry Hi-Tech. 2007; 18(3) 27-9. 


 


   7. Wijnkoop, IL et al. “Probiotic and probiotic influence beyond the intestinal tract” Nutr Rev. 2007;65(11): 469-89.


 


   8. Parracho, H et al. “Differences between the gut microflora of children with autistic spectrum discorders and that of healthy children” J Med Micro Bio. 2005; 54(10): 987-991.


 


   9. Hatakka, K et al. “Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial” BMJ. 2001;322(7298):1327.


 


  10. Van Niel, CW et al. “Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis” Pediatrics. 2002;109(4):678-684.


 


  11. Henker, J et al. “Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers” Pediatr Infect Dis J. 2008;27(6):494-499.


 


  12. Canani, RB et al. “Probiotics for treatment of acute diarrhea in children; randomized clinical trial of five different preparations” BMJ. 2007;335(7615): 340.


 


  13. Szajewska H et al. “Probioitcs in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy” J Pediatr Gastroenterol Nutr. 2006;42:454-75.


 


  14. Isolauri E. “Probiotics for infectious diarrhea” Gut.2003;52:436-7.


 


  15. Saavedra JM et al. “Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus” Lancet. 1994;344:1046-9.


 


  16. Davidson, GP et al. “Probiotics in intestinal disorders” Curr Opin Pediatr. 2000;12:477-81.


 


  17. Elmer, GW et al. “Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections” JAMA. 1996;275:870-6.


 


  18. Ibid.


 


  19. Huang JS et al. “Efficacy of probiotic use in acute diarrhea in children: a meta-analysis” Dig Dis Sci. 2002;109:678-84.


 


  20. Van Niel, CW et al. “Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis” Pediatrics. 2002;109:678-84.


 


  21. Allen, SJ et al. “Probioitics for treating infectious diarrhea” Cochrane Database Syst Rev. 2004;(2):CD003048.


 


  22. Johnston, BC et al. “Probiotics for the prevention of pediatric antibiotic-associated diarrhea” Cochrane Database Syst Rev. 2007;(2): CD004827.


 


  23. Parvez, S et al. “Probiotics and their fermented food products are beneficial for health” J Appl Microbiol. 2006;100(6):1171-1185.


 


  24. Borowiec, AM et al. “The role of probiotics in management of irritable bowel syndrome” Curr Gastroenterol Rep. 2007;9(5):393-400.


 


  25. Guslandi, M. “Probiotic agents in the treatment of irritable bowel syndrome” J Int Med Res. 2007;35(5):583-9.


 


  26.  Brenner, D. “Review of Probiotic Trial Research Finds Only Bifantis® Able to Claim Efficacy versus Placebo for IBS Symptoms.”www.bifantis.com/images/bifantis_07_release.pdf


 


  27. Bassett, JT et al. “A review of irritable bowel syndrome and an update on therapeutic approaches” Expert Opin Pharmacother. 2008;9(7):1129-43.


 


  28. Nikfar, S et al. “Efficacy of Probiotics in Irritable Bowel syndrome: a meta-analysis of randomized, controlled trials” Dis Colon Rectum. 2008: [epub ahead of print]. DOI:10.1007/s10350-008-9335-z


 


  29. Niedzielin, K et al. “A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome” Eur J Gastroent & Hepat. 2001;(13)1143-7.


 


  30. O’Mahony, L et al. “Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles” Gastroenterology. 2005;128(3):541-51.


 


  31. Whorewell, PJ et al. “Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome” Am J Gastroenterology. 2006;101(7):1581-90.


 


  32. Hertig, VL et al. “Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome” Nurs Res. 2007;56(6):399-406.


 


  33. Laurent, D et al. “Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial” J nutres. 2008;28(1):1-5.


 


  34. Zareie, M et al. “Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress” Gut. 2006;55(11):1553-1560.


 


  35. Kajander, K et al. “Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota” Aliment Pharmacol Ther. 2008;27(1):48-57.


 


  36. Dash, S.K. A Consumer’s Guide to Probiotics. Freedom Press, 2005: 86-7.


 


  37. Bisson, JF et al. “Effects of Different Probiotic Formulations on the Travelers’ Diarrhea Model in Rats” 2007; unpublished study conducted by Institut Rosell-Lallemand.  


 


  38. Briand, V et al. “Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler’s diarrhea: a randomized, double-blind, controlled study” Clin Infect Dis. 2007;43(9):1170-5.


 


  39. McFarland, LV. “Meta-analysis of probiotics for the prevention of traveler’s diarrhea” Travel Med Infect Dis. 2007;5(2):97-105.


 


  40. McFarland, LV. “Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease” Am J Gastroenterol. 2006;101(4):812-22.


 


  41. Stadlbauer, V et al. “Effect of Probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis” J Hepatol. 2008;48(6):945-51.


 


  42. Anukam, KC et al. “Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderated diarrhea and increases CD4 count in HIV/AIDS patients” J Clin Gastroenterol. 2008; 42(3): 239-243.


 


  43. Kekkonen, RA et al. “The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners” Int J Sport Nutr Exer Metab. 2007; 17(4): 352-363.


 


  44. Cox, AJ et al. “Oral administration of the probiotic Lactobacillus fermentum VR1-003 and mucosal immunity in endurance athletes” Br J Sports Med. 2008; doi 10.1136/bjsm.2007.044628


 


  45. Berman, S et al. “Daily ingestion of a nutritional probiotic supplement enhances innate immune function in healthy adults” Nutr Res. 2006;26(9):454-459.


 


  46. MacFarlane, S et al. “Review article: prebiotics in the gastrointestinal tract” Aliment Pharmacol Ther. 2006;24(5) 701-714.


 


  47. Paineau, D et al. “The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders” Br J Nutr. 2008;99:311-18. DOI:10.1017/S000711450779894X.


 


  48. Rozan, P et al. “Effects of lifelong intervention with an oligofructose-enriched inulin in rats on general health and lifespan” B J Nutr. 2008; doi:10.1017/S0007114508975607. http://www.ncbi.nlm.nih.gov/pubmed/18405402


 


  49. Saulnier, DMA et al. “Effects on a synbiotic on biomarkers of oxidative stress and faecal microbiota in healthy adults: results of a cross-over double-blind placebo-controlled trial”  Proceedings of the Nutrition Society. 2007;66:101A.


 


  50. Heyman, MB et al. “Lactose intolerance in infants, children and adolescents” Pediatrics. 2006;118(3):1279-86.


 


  51. Donnelly, MT. “Is exocrine pancreatic insufficiency in adult celiac disease a cause of persisting symptoms?” Aliment Pharmacol Ther. 2007;25(3):264-71.


 


  52. Suarez, F. et al. “Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal” Digestive Disease and Sciences. 1999; 44(7):1317-21(5).